国际肿瘤学杂志 ›› 2011, Vol. 38 ›› Issue (12): 903-905.

• 综述 • 上一篇    下一篇

血清标志物CYFRA21-1与肿瘤

庄珊珊, 方裕森, 陈炯玉   

  1. 515041汕头大学医学院附属肿瘤医院检验科
  • 出版日期:2011-12-08 发布日期:2011-11-25
  • 通讯作者: 陈炯玉,E-mail: kinyny@21cn.com E-mail:kinyny@21cn.com

Sserum markers CYFRA21-1 in cancer

ZHUANG  Shan-Shan, FANG  Yu-Sen, CHEN  Jiong-Yu   

  1. Department of Laboratory, Cancer Hospital of Shantou University Medical College,  Shantou 515041, China
  • Online:2011-12-08 Published:2011-11-25
  • Contact: CHEN Jiong-Yu,E-mail: kinyny@21cn.com E-mail:kinyny@21cn.com

摘要: 研究发现细胞角蛋白19片段抗原21-1(CYFRA21-1)含量在多种恶性肿瘤患者血清中特异性升高。作为一种上皮来源性质的肿瘤标志物,血清CYFRA21-1水平检测对于恶性肿瘤的筛查诊断、疗效评估、复发监测和预后判断具有重要的临床应用意义。

Abstract: Studies demonstrate that the serum levels of cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) are high in various cancer types. As a novel epithelial cells derived tumor marker, detection of the serum level of CYFRA21-1 is of great clinical significance for screening and diagnosis, curative effect evaluation, recurrent monitoring and prognosis assessment for cancer patients.